High Demand in NGS Based RNA Seq Market 2027 - Leading Players Fisher Scientific, Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, BGI, Oxford Nanopore Technologies, Perkinelmer and Eurofins Scientific

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

NGS Based RNA Seq Market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018- 2027.The report highlights the trends prevalent in the global NGS- based RNA- seq market and the factors driving the market along with those that act as deterrents to its growth.

Global NGS- based RNA- seq market, based on the product & services is segmented into sample preparation, sequencing services, sequencing platform & consumables and data analysis, storage & management. The sample preparation segment is further bifurcated into method and workflow step segments. In 2017, sequencing platform & consumables segment held the largest share, by product& services. Additionally, the data analysis segment is anticipated to grow at a significant rate during the forecast period.

Get PDF Sample Copy of this Report @ http://bit.ly/2EVaJaO

Top Leading Market Players:

1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

The market players are focused towards bringing new and innovative product launches to sustain their position in the market. For instance, in October 2018, Agilent Technologies Inc. launched Agilent OnePGT, a genome- wide, next- generation sequencing (NGS) solution for preimplantation genetic testing (PGT).

Global NGS- based RNA- seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS- based RNA- seq market, in the coming years.

The NGS Based RNA Seq Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 – 2027, considering 2018 as the base year and 2018 – 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

The report segments the global NGS- based RNA- seq market as follows:

Global NGS- Based RNA- Seq Market - By Product & Services

• Sample Preparation
• Method
• Manual Method
• Automated Method
• Workflow Step
• Library Preparation & Target Enrichment
• Fragmentation, End Repair & Size Selection
• Quality Control
• Sequencing Services
• Sequencing Platform & Consumables
• Data Analysis, Storage & Management

Global NGS- Based RNA- Seq Market - By Technology

• Sequencing By Synthesis
• Nanopore Sequencing
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing

Global NGS- Based RNA- Seq Market - By Application

• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

Global NGS-Based RNA-Seq Market - By End User

• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Biotechnology & Pharmaceutical Companies
• Others

Request for Buy Report @ http://bit.ly/2EVHzbr

Reason to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global NGS Based RNA Seq Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the NGS Based RNA Seq, thereby allowing players to develop effective long term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

This release was published on openPR.